Rethinking Schizophrenia: Optimizing Care Pathways in Europe from the First Episode of Psychosis to Long-Term Care
BackgroundThe European Brain Council project 'Rethinking Schizophrenia' aims to examine the existing state of patient care pathways across Europe.The study objectives of the Phase 2 were to evaluate the current models of schizophrenia care on mental health outcomes, access and satisfaction with care, and to identify the foundations of integrated care pathways for young people with first episode psychosis. MethodsUsing the care pathway, a questionnaire was developed and anonymously disseminated to mental health professionals in nine European countries (Belgium, Denmark, France, Germany, Hungary, Italy, Poland, Spain, and United Kingdom).The survey included 45 questions and addressed the quality and continuity of care from the first onset of psychosis to long-term care, including assessment of the mental health care systems. ResultsA total of 203 responses were obtained.The majority of mental health professionals were psychiatrists (75%), followed by psychologists (11%), nurses (7%), social workers (2%), GPs and others (5%).The responses were analyzed qualitatively.The results revealed dissatisfaction with the current state of schizophrenia care systems and significant variability in quality of care.The factors that affect the care pathways most are assessment and early intervention services, continuity of care, availability of various types of services and treatments, collaborative decision-making, and utilization of new technologies. ConclusionsA comprehensive, integrated approach is essential to improve schizophrenia care across Europe.This strategy emphasizes early intervention, equitable access to treatments, coordinated care models, psychosocial support, and long-term recovery through a biopsychosocial framework and emerging technologies.
Authors
- Piotr Toczyski (ORCID: https://orcid.org/0000-0003-1218-5623)
- Péter Kéri
- W. Gaebel
- Jerzy Samochowiec (ORCID: https://orcid.org/0000-0003-1438-583X)
- Vinciane Quoidbach (ORCID: https://orcid.org/0000-0002-4554-6432)
- A. Catalan (ORCID: https://orcid.org/0000-0002-0418-7904)
- Peter Falkai
- István Bitter (ORCID: https://orcid.org/0000-0002-9464-4709)
- J.K. Rybakowski
- Julian Beezhold (ORCID: https://orcid.org/0000-0001-9857-1669)
- Patrice Boyer
- Celso Arango
- Joao Vasco Santos
- Pavel Mohr
- Sonia Dollfus
- Geert Dom
- B. Chaumette
- Paolo Fusar-Poli
- Agata Szulc
- Antonio Vita
- Cedric Duarte
- Andreas Meyer-Lindenberg
- Merete Nordentoft
- Oliver Howes
Institutions
- Semmelweis University (HU)
- Poznan University of Medical Sciences (PL)
- University of Copenhagen (DK)
- University of Antwerp (BE)
- Inserm (FR)
- University of the Basque Country (ES)
- Universidade do Porto (PT)
- King's College London (GB)
- University of Campania "Luigi Vanvitelli" (IT)
- Norfolk and Suffolk NHS Foundation Trust (GB)
- Heidelberg University (DE)
- Medical University of Warsaw (PL)
- Hospital Universitario La Paz (ES)
- University Hospital Heidelberg (DE)
- Brescia University (US)
- Robert Schumann University of Music and Media (DE)
- University of Warwick (GB)
- Department of Public Health (AS)
- Normandie Université (FR)
- Howard Brain Sciences Foundation (US)
- München Klinik (DE)
- The Maria Grzegorzewska University (PL)
- European Brain Research Institute (IT)
- FHU Neurovasc (FR)
- University Medical Centre Mannheim (DE)
- Global Alliance of Mental Illness Advocacy Networks-Europe (BE)
- Heinrich Heine University Düsseldorf (DE)
- Pomeranian Medical University (PL)
- University of Brescia (IT)
Publication Details
- Journal
- European Psychiatry
- Published
- 2026-02-16
- DOI
- https://doi.org/10.1192/j.eurpsy.2026.10172
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00